A retrospective comparative study short-term administration of oral Relugolix before single-port laparoscopic-assisted vaginal hysterectomy for symptomatic uterine myomas
Latest Information Update: 20 Jul 2022
At a glance
- Drugs Leuprorelin (Primary) ; Relugolix (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
Most Recent Events
- 20 Jul 2022 New trial record
- 01 Jul 2022 Results published in the Journal of Obstetrics and Gynaecology Research